Brandinium

Trademark search for:

BUSCOZOL

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2007-03-14 — Application filed
  • 2007-06-14 — Sn assigned for sect 66a appl from ib
  • 2007-06-19 — Limitation of goods/services from ib entered
  • 2007-06-21 — Application filed
  • 2007-06-25 — Final disposition recorded
  • 2007-06-25 — Assigned to examiner
  • 2007-06-26 — Office action issued
  • 2007-06-26 — Office action issued
  • 2007-06-26 — Office action issued
  • 2007-07-13 — Office action issued
  • 2007-09-17 — Paper received
  • 2007-10-25 — Approved for pub - principal register
  • 2007-10-25 — Amendment from applicant entered
  • 2007-10-25 — Assigned to lie
  • 2007-10-25 — Correspondence received in law office
  • 2007-10-26 — Law office publication review completed
  • 2007-11-14 — Notice of publication
  • 2007-12-04 — Published for opposition
  • 2008-02-19 — Registered-principal register
  • 2008-05-19 — Final disposition recorded
  • 2008-05-20 — Final disposition recorded
  • 2008-05-20 — Final disposition recorded
  • 2008-06-06 — Final disposition recorded
  • 2009-09-25 — Change of owner received from ib
  • 2014-09-26 — Cancelled section 71
  • 2015-05-26 — Total invalidation of reg ext protection created
  • 2015-08-10 — Total invalidation of reg ext protection sent to ib
  • 2015-08-10 — Invalidation processed
  • 2015-08-28 — Total invalidation processed by the ib
  • 2017-03-15 — Final status recorded
  • 2017-09-29 — Death of international registration
  • 2017-09-29 — Notification of effect of cancellation of intl reg mailed

Owner Information

Boehringer Ingelheim Pharma GmbH & Co. KG
DE
Boehringer Ingelheim Pharma GmbH & Co. KG
DE
Boehringer Ingelheim Pharma GmbH & Co. KG
DE
Boehringer Ingelheim Pharma GmbH & Co. KG
DE

Correspondent

MARTIN J. BERAN OSTROLENK, FABER, GERB & SOFFEN, LLP
1180 AVENUE OF THE AMERICAS
NEW YORK, NY 10036-8403
UNITED STATES

Filing Details

Filing Date:
2007-03-14
Status Date:
2017-03-15
Category:
Pharmaceuticals
Filing Year:
2007

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.